ViaLuxe Laser System (FLigHT Procedure)
Open-angle glaucoma
RegulatoryActive
Key Facts
About ViaLase
ViaLase is a clinical-stage ophthalmic device company developing the ViaLuxe Laser System for the noninvasive treatment of open-angle glaucoma. The company's FLigHT procedure utilizes femtosecond laser technology and proprietary imaging to perform a standalone, non-incisional intervention, positioning it as a potential disruptor between ineffective medications and invasive surgeries. With its products not yet for sale pending regulatory clearance, ViaLase is targeting a significant unmet need in a large, chronic disease market dominated by treatments with compliance, efficacy, and safety limitations.
View full company profileTherapeutic Areas
Other Open-angle glaucoma Drugs
| Drug | Company | Phase |
|---|---|---|
| VisiPlate | Avisi | Pivotal Trial |
| MINIject® | iSTAR Medical | Pivotal Trial (US) / Post-Market (EU) |